Astellas is to work with UK biotech Adaptimmune ... and chimeric antigen receptors (CARs), important building blocks for cell therapies.. Based in Oxfordshire, Adaptimmune also has human leukocyte ...

The company said in its third-quarter results call that it is already building commercial manufacturing capacity for zolbetuximab as it anticipates the readout of the two phase 3 trials. Astellas ...

Cancer is well represented in the Astellas Pharma portfolio and pipeline, but the drugmaker has made diversification a key part of its growth strategy. Newer products in its drug lineup include a ...